Phase I Trial of Combination Pegylated Liposomal Doxorubicin (Doxil), Vinorelbine, and Gemcitabine
Phase of Trial: Phase I
Latest Information Update: 03 Mar 2010
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Gemcitabine (Primary) ; Vinorelbine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 03 Mar 2010 Additional trial identifier (P30CA043703) and inclusion/exclusion criteria identified as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual end date (Feb 2005) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual patient number (10) added as reported by ClinicalTrials.gov.